These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21125369)

  • 1. [Pastes and individual formulations].
    Hautarzt; 2010 Dec; 61(12):1010-11. PubMed ID: 21125369
    [No Abstract]   [Full Text] [Related]  

  • 2. [Unexpected instabilities].
    Wolf G
    Hautarzt; 2013 Jun; 64(6):398-9. PubMed ID: 23914372
    [No Abstract]   [Full Text] [Related]  

  • 3. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin.
    Gamer AO; Leibold E; van Ravenzwaay B
    Toxicol In Vitro; 2006 Apr; 20(3):301-7. PubMed ID: 16182508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of Piolizin ointment in suppurative skin diseases].
    Glad'ko VV
    Voen Med Zh; 1998 Dec; 319(12):30-1. PubMed ID: 10051836
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glucocorticoid containing extemporaneous formulations. Rational for use in dermatology].
    Högger P
    Pharm Unserer Zeit; 2010 Jul; 39(4):294-9. PubMed ID: 20589803
    [No Abstract]   [Full Text] [Related]  

  • 6. [Production and testing of skin protective ointments].
    Popescu G; Braileanu C
    Pharm Prax; 1966; 12():274-6. PubMed ID: 5985092
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiments with antimicrobial treatment of dermatologic preparations containing peracetic acid. 2].
    Kühn H
    Pharmazie; 1978 May; 33(5):292-3. PubMed ID: 27826
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prescription tips: ready-made dermatologic agents in individual prescriptions].
    Hautarzt; 2008 Apr; 59(4):270-1. PubMed ID: 18389156
    [No Abstract]   [Full Text] [Related]  

  • 9. Galenics of dermal products--vehicles, properties and drug release.
    Daniels R; Knie U
    J Dtsch Dermatol Ges; 2007 May; 5(5):367-83. PubMed ID: 17451381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical zinc oxide vs. salicylic acid-lactic acid combination in the treatment of warts.
    Khattar JA; Musharrafieh UM; Tamim H; Hamadeh GN
    Int J Dermatol; 2007 Apr; 46(4):427-30. PubMed ID: 17442091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary: Enhanced healing of surgical wounds of the lower leg using weekly zinc oxide compression dressings.
    Treadwell T
    Dermatol Surg; 2011 Feb; 37(2):166-7. PubMed ID: 21324027
    [No Abstract]   [Full Text] [Related]  

  • 12. [Considerations on dermatological magistral preparations].
    Oslet J
    J Pharm Belg; 1966; 21(3):163-202. PubMed ID: 5914546
    [No Abstract]   [Full Text] [Related]  

  • 13. Magistral formulations and pruritus therapy - What is established, what is confirmed, what is new?
    Staubach P; Metz M
    J Dtsch Dermatol Ges; 2013 Nov; 11(11):1049-55. PubMed ID: 24119119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basics of compounding: tips and hints, Part 3: compounding with ointments, creams, pastes, gels, and gel-creams.
    Allen LV
    Int J Pharm Compd; 2014; 18(3):228-30. PubMed ID: 25306771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reaction and effectiveness of prednisolone in zinc oxide containing dermatologic agents].
    Müller R; Umbreit J; Liebetrau E; Nekwasil J
    Dermatol Monatsschr; 1989; 175(2):82-6. PubMed ID: 2721800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the rheological properties of protective hydrophilic ointments and pastes].
    Glon' ZI; Salo DP; Bashura GS; Tretinnik VIu
    Farm Zh; 1974; (1):71-4. PubMed ID: 4463034
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of the Vehicle and Antibiotic Formulation on Cytotoxicity of Triple Antibiotic Paste.
    Faria G; Rodrigues EM; Coaguila-Llerena H; Gomes-Cornélio AL; Neto Angéloco RR; Swerts Pereira MS; Tanomaru Filho M
    J Endod; 2018 Dec; 44(12):1812-1816. PubMed ID: 30477667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis.
    Mraz S; Leonardi C; Colón LE; Johnson LA
    J Dermatolog Treat; 2008; 19(6):354-9. PubMed ID: 18923991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatologic vehicles.
    Ricciatti-Sibbald D; Sibbald RG
    Clin Dermatol; 1989; 7(3):11-24. PubMed ID: 2680013
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing dermatological formulations of retinoic acid.
    Schlichting DA; Wooding WM; Brown M
    J Pharm Sci; 1973 Mar; 62(3):388-91. PubMed ID: 4691697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.